Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Clinical, hormonal and pathomorphological markers of somatotroph pituitary neuroendocrine tumors predicting the treatment outcome in acromegaly.
Tomasik A, Stelmachowska-Banaś M, Maksymowicz M, Czajka-Oraniec I, Raczkiewicz D, Zieliński G, Kunicki J, Zgliczyński W. Tomasik A, et al. Front Endocrinol (Lausanne). 2022 Sep 16;13:957301. doi: 10.3389/fendo.2022.957301. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36187106 Free PMC article.
AIM: This study aimed to assess whether clinical, biochemical, imaging and pathological characteristics can predict surgical remission and response to first-generation somatostatin receptor ligands (SRLs) and pasireotide-LAR in acromegaly. ...Fasting GH concentration <3 …
AIM: This study aimed to assess whether clinical, biochemical, imaging and pathological characteristics can predict surgical remissio …
Transcriptomic Classification of Pituitary Neuroendocrine Tumors Causing Acromegaly.
Rymuza J, Kober P, Rusetska N, Mossakowska BJ, Maksymowicz M, Nyc A, Baluszek S, Zieliński G, Kunicki J, Bujko M. Rymuza J, et al. Cells. 2022 Nov 30;11(23):3846. doi: 10.3390/cells11233846. Cells. 2022. PMID: 36497102 Free PMC article.
They differ in expression of numerous genes including those involved in growth hormone secretion and known prognostic genes. Transcriptomic subgroups can be distinguished by determining the expression of marker genes. ...Transcriptomic group 2 tumors are the most common (4 …
They differ in expression of numerous genes including those involved in growth hormone secretion and known prognostic genes. Transcri …
MiR-320a Acts as a Tumor Suppressor in Somatotroph Pituitary Neuroendocrine Tumors by Targeting BCAT1.
Zhao S, Li B, Gao H, Zhang Y. Zhao S, et al. Neuroendocrinology. 2024;114(1):14-24. doi: 10.1159/000533549. Epub 2023 Aug 17. Neuroendocrinology. 2024. PMID: 37591221
Pan-cancer analyses demonstrated that high BCAT1 expression often indicates a poor prognosis. CONCLUSION: Our findings illustrate that miR-320a may function as a tumor suppressor and BCAT1 may promote tumor progression. miR-320a may inhibit the growth of somatotroph PitNET …
Pan-cancer analyses demonstrated that high BCAT1 expression often indicates a poor prognosis. CONCLUSION: Our findings illustrate tha …